corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 16826

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Swiss Fine Drug Firms $5.7M for Price-Fixing
Pharma Live 2009 Dec 1
http://pharmalive.com/news/index.cfm?articleID=670072


Full text:

The Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG were fined a total of 5.7 million francs ($5.7 million) by competition regulators on Tuesday for alleged price fixing of drugs for erectile dysfunction.

The Swiss Competition Commission said the prices of Viagra, Cialis and Levitra were fixed in the form of public price recommendations.

It didn’t say how much each company was fined, and a competition spokesman declined to provide the information.

The three companies rejected the allegation.

“We are surprised by the decision and we believe the public price recommendation for Cialis was in full compliance with Swiss competition law,” said Petra Streit, an Eli Lilly spokeswoman.

Bayer was examining how it could challenge the fine, according to a statement.

“We’re of the opinion that this decision will not survive a court examination,” Pfizer added.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.